We are live on ! Find out more
DH icon

Definitive Healthcare

129 hedge funds and large institutions have $388M invested in Definitive Healthcare in 2025 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 23 increasing their positions, 57 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 18

7% more funds holding

Funds holding: 121129 (+8)

2% more capital invested

Capital invested by funds: $382M → $388M (+$5.75M)

0.51% more ownership

Funds ownership: 91.26%91.78% (+0.51%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

60% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 57

Holders
129
Holders Change
+8
Holders Change %
+6.61%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
26
Increased
23
Reduced
57
Closed
18
Calls
$50K
Puts
Net Calls
+$50K
Net Calls Change
-$84K
Name Holding Trade Value Shares
Change
Change in
Stake
AI
1
Advent International
Massachusetts
$254M
Goldman Sachs
2
Goldman Sachs
New York
$29.7M -$5.72M -1,432,475 -16%
BlackRock
3
BlackRock
New York
$12.7M +$31.2K +7,812 +0.3%
Vanguard Group
4
Vanguard Group
Pennsylvania
$11.2M -$614K -153,826 -5%
PCM
5
Palisade Capital Management
New Jersey
$8.7M -$161K -40,361 -2%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$8.42M +$134K +33,612 +2%
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$7.32M +$1.58M +394,860 +28%
Morgan Stanley
8
Morgan Stanley
New York
$5.68M -$608K -152,391 -10%
Arrowstreet Capital
9
Arrowstreet Capital
Massachusetts
$4.94M +$507K +127,055 +12%
State Street
10
State Street
Massachusetts
$4.76M -$63.6K -15,932 -1%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$4.3M -$288K -72,248 -6%
New York State Common Retirement Fund
12
New York State Common Retirement Fund
New York
$3.11M
Renaissance Technologies
13
Renaissance Technologies
New York
$2.72M -$133K -33,191 -5%
AQR Capital Management
14
AQR Capital Management
Connecticut
$2.41M -$286K -71,662 -11%
Northern Trust
15
Northern Trust
Illinois
$1.99M +$581K +145,398 +42%
Corient Private Wealth
16
Corient Private Wealth
Florida
$1.83M +$1.8M +450,017 New
Bank of America
17
Bank of America
North Carolina
$1.67M -$1.43M -358,519 -47%
UBS Group
18
UBS Group
Switzerland
$1.53M -$397K -99,431 -21%
Charles Schwab
19
Charles Schwab
California
$1.52M -$110K -27,553 -7%
Jane Street
20
Jane Street
New York
$1.31M -$18.4K -4,618 -1%
Citigroup
21
Citigroup
New York
$1.17M +$636K +159,179 +123%
Connor, Clark & Lunn Investment Management (CC&L)
22
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.04M -$422K -105,806 -29%
CEI
23
Clark Estates Inc
New York
$973K
TAM
24
Tocqueville Asset Management
New York
$873K
Bank of New York Mellon
25
Bank of New York Mellon
New York
$814K +$20.2K +5,049 +3%

DH Hedge Fund Activity: Q3 2025 in Review

129 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Definitive Healthcare (DH) for Q3 2025, worth a combined $388M — up 1.5% from $382M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new DH positions and 18 closed out — a net gain of 8 holders — while 23 added to existing stakes and 57 trimmed.

The largest buyer was Corient Private Wealth, opening a new position worth an estimated $1.8M. The largest seller was Goldman Sachs, cutting an estimated $5.72M.

  • 129 institutional investors held Definitive Healthcare (DH) as of Q3 2025, up from 121 in Q2 2025.
  • Funds reported $388M of Definitive Healthcare stock for Q3 2025, up 1.5% quarter-over-quarter.
  • 26 funds opened new Definitive Healthcare positions in Q3 2025 and 18 closed out, a net change of +8 holders.
  • The largest Definitive Healthcare buyer in Q3 2025 was Corient Private Wealth, an estimated $1.8M added.
  • The largest Definitive Healthcare seller in Q3 2025 was Goldman Sachs, an estimated $5.72M sold.

Based on aggregated 13F filings for Q3 2025.